
LifeStance Health Gr (LFST) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $0.06 | $0.07 | -14.3 % |
| Q2 | Aug 6, 2026 | $0.06 | $0.07 | -14.3 % |
| Q1 | May 7, 2026 | $0.04 | $0.05 | -20.0 % |
| Q4 | Feb 25, 2026 | $0.03 | $0.05 | -40.0 % |
Quarterly Revenue (Billions)
LifeStance Health Gr (LFST) publicó su última previsión de noviembre 5, 2026 para Q4 2026. La compañía estimó ingresos en un rango de $446M - $466M para el período.
En comparación con la previsión anterior, LifeStance Health Gr reducido redujo su previsión de ingresos desde un rango anterior de $1.74B - $1.76B.
LifeStance Health Gr ha emitido 34 actualizaciones de orientación entre el noviembre 8, 2022 y el noviembre 5, 2026. During this period, the company raised its outlook 12 times and lowered it 15 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.07 | $0.07 | $0.05 | $0.05 |
| Actual | $0.06 | $0.06 | $0.04 | $0.03 |
| Surprise | -14.3% | -14.3% | -20.0% | -40.0% |
| Revenue | ||||
| Estimate | $431.0M | $414.4M | $386.5M | $378.0M |
| Actual | $455.9M | $435.4M | $403.5M | $382.2M |
| Surprise | +5.77% | +5.07% | +4.38% | +1.10% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.08 | $0.09 | $0.04 | $0.05 |
| Revenue | ||||
| Consensus | $436.6M | $455.2M | — | — |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $455.90M | $431.02M | 5.77 % |
| Q2 | Aug 6, 2026 | $435.35M | $414.36M | 5.07 % |
| Q1 | May 7, 2026 | $403.48M | $386.53M | 4.38 % |
| Q4 | Feb 25, 2026 | $382.20M | $378.05M | 1.10 % |